bucindolol

bucindolol

An investigational, nonselective beta-blocker with vasodilating properties that reached phase-III (BEST) trials, but was dropped from development thereafter.

bucindolol

Bextra Cardiology An investigational nonselective beta-blocker with vasodilating properties; removed from marketplace